Artiva Biotherapeutics, Inc. - 8-K Filing

Artiva Biotherapeutics set its 2026 annual meeting for September 8 and provided stockholder submission deadlines. (Items: 8.01 Other Events)

SEC EDGAR ·

Tickers: $ARTV

Read the full article at SEC EDGAR

More Regulatory news